WT1 Antikörper (AA 277-505)
Kurzübersicht für WT1 Antikörper (AA 277-505) (ABIN467409)
Target
Alle WT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 277-505
-
Spezifität
- Human WT1. Predicted cross-reactivity based on amino acid sequence homology: mouse (97 % ), rat (97 %), pig (97 %), zebrafish (85 %).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Recombinant protein fragment containing a sequence corresponding to a region within amino acids 277 and 505 of Human WT1.
Type of Immunogen: Recombinant protein
-
-
-
-
Applikationshinweise
-
Approved: ICC, IF, WB
Not recommended for: IHC-P -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7, 10 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C. Avoid freeze-thaw cycles.
-
-
- WT1 (Wilms Tumor 1 (WT1))
-
Andere Bezeichnung
- WT1 / Wilms Tumor 1
-
Hintergrund
-
Name/Gene ID: WT1
Synonyms: WT1, GUD, EWS-WT1, Amino-terminal domain of EWS, WAGR, WIT-2, Wilms tumor protein, AWT1, Wilms tumor 1, WT33, NPHS4 -
Gen-ID
- 7490
-
UniProt
- P19544
-
Pathways
- Tube Formation
Target
-